Exam 4-FINALLLL Flashcards
Methotrexate Mechanism of Action
inhibits the critical enzyme that cycles the cofactor that makes folate DHFR-dihydrofolate reductase
DHFR is involved in the synthesis of thymine from uracil
Methotrexate Side Effects and Interactions
ulcerative stomatitis, leukopenia, abdominal stress
Do not take NSAIDs before or during because they increase blood concentration of methotrexate
Leflunomide
Prodrug of antirheumatic metabolite A77 1726 which suppresses lymphocytes proliferation and inhibits cytokine synthesis
side effect: liver toxicity
Methotrexate
antimetabolite of folic acid
Leflunomide Mechanism of Action
A77 1726 inhibits dihydro-orotate dehydrogenase required for pyrimidine biosynthesis
Inhibits tyrosine kinase associated with cytokines possibly interfering with T and B cell production
Thalidomide indication
erythema nodosum leprosum (ENL)
Thalidomide Mechanism of Action
Unclear
May decrease circulating TNF-(a) in ENL but increase it in HIV
Echinacea
stimulates the innate immune system, increases phagocytosis and release from macrophages, Tcells of TNFs, interferons
possibly active polysaccharides
don’t use for more than 8 wks because can induce autoimmune process
Astragalus
Chinese medicine for hepatitis, cancer, colds, URIs, heart disease
generally safe
Levamisole
Immunostimulant
enhance 5-FU toxicity
mimics thymic hormone thymopoietin
inhibits most isoforms of alkaline phosphatase
restores depressed function of B/T cells, monocytes, macrophages
Imiquimod
treats actinic keratosis external, genital, and perianal warts from HPV
Toll Like Receptor agonist-7 agonists, stimulates immune system to produce interferon(a) and others. Activates macrophages, NK, TH1, Bcells.
Topical creams
active immunization involves stimulation with an antigen to develop immunological defenses against a future exposure
vaccine
passive immunization involves administering pre-formed antibodies from an external source
antibodies: immunoglobulins, monoclonal antibodies
Epoetin alfa, Darbepoetin alfa, granulocyte-colony stimulating factor, granulocyte macrophage colony stimulating factor
growth factors
Active immunization vaccine
protection not immediate because body responds and produces antibodies
excess of TH2 cells produced-imbalance leads to asthma, allergies
denaturing disinfectant kills pathogen, allows recovery of the surface antigens
killed pathogen vaccines
pass the pathogen through many generations of host animals to yield low virulent strain
live/attenuated pathogen vaccines
cowpox used in place of smallpox virus
live/ attenuated related strain vaccines
isolate the surface antigen from the pathogen, purify it and reconstitute into a vaccine preparation
cellular antigen from a pathogen vaccine
clone a piece of DNA encoding the surface antigen from the pathogen and over produce the antigen in E coli etc
genetically engineered pathogen vaccine
simple vaccine
contains only one kind of antigen or strain
multivalent vaccine
contains two or more kinds of antigens or strains that cause the same disease..full protection
polyvalent vaccine
contains two or more kinds of antigens or strains that cause different diseases–convenience
types of vaccine dosing
single dose, multiple dosing regimen, booster dose, co-administered vaccine
types of vaccines
viral, bacterial, toxoids, cancer/autoimmune
conjugate vaccines
covalently linked polysaccharide antigen and a carrier protein from the bacterium
toxoids
denatured toxin that has been inactivated
DNA vaccination advantage
expression of whole proteins, so HLA alleles do not matter
passive immunization-antibodies
immediate protection administered to people who are already ill and lasts 1-3 months 1. Immunoglobulins 2. Monoclonal Antibodies neutralize toxic molecules eliminate target cells
How antibodies can eliminate target cells
cell growth control
macrophage clearance
complement-mediated cytotoxicity
antibody dependent cell mediated cytotoxicity
human immunoglobulins
rabies, tetanus, hep B, Rho
animal immunoglobulins
digoxin immune fab–sheep IgG used for digoxin overdose. binds TO digoxin
antiithymocyte globulin
gamma globulin from rabbit immunized with human thymocytes
polyclonal mix
directly kills T lymphocytes
binds to cell surface molecules that regulate cell function
indication: kidney rejection, aplastic anemia if not suitable for bone marrow transplant
monoclonal antibodies
synthesized from a single clone of B lymphocytes or plasma cells
-ximab
chimeric antibody (2/3rd human)
-umab
human antibody
-zumab
humanized antibody (90% human)
muromonab
attaches to T cell receptor
from mice that interacts with human CD3
instantly decreases T cells in blood, used 10-14 days and can’t be used again
side effect: cytokine release syndrome
-omab
mouse antibody
basiliximab
attaches to T cell receptor
chimeric maB that binds to IL2 receptor of activated Tcells
IL2 aka CD25
used with cyclosporine or tacrolimus+corticosteroids
belatacept
attaches to T cell receptor
prevent kidney rejection
soluble fusion protein CTLA4-Ig contains CTLA4 fused to Fc domain of human IgG antibody
produced by recombinant DNA tech
binds CD80 and CD86
Ways to treat malignancies with MAbs
enhance effector function
pre-target
indirect arming
direct arming
rituximab
for lymphomas
first MAb approved in USA for follicular lymphoma
chimeric IgG binds to CD20 which is on 90% of non-Hodgkin’s lymphomas
alemtuzumab
for lymphomas
humanized MAb directed against CD52 which is on mature lymphocytes
used for Bcell chronic lymphocytic leukemia
brentuximab vedotin
for lymphomas
chimeric IgG antibody specific for CD30+drug MMAE that disrupts microtubules+covalent linker
treatment of Hodgkin’s lymphoma and sALCL (non)
binding internalizes ADC-CD30 complex, MMAE released, microtubules network disrupts, apoptosis
tositumomab
for lymphomas
mouse IgG MAb linked to iodine131
antiCD20 for non-hodgkins
induces normal immune reactions and radioimmunoconjugates deliver cytotoxic ionization radiation
kills cells 1-2 mm away that are inaccessible to antibody
y-90-labeled ibritumomab tiuxetan
for lymphomas
mouse IgG anti CD20 radiolabeld